Company profile
Xcorporeal, Inc.
OTC: XCRP · Healthcare · Medical - Devices
PublicHQ Lake Forest, Reports USD
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 44
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ market scale, return on assets
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$23.0M
Employees
24
as of 2026-08-03
Market cap
$1.5k
as of 2026-08-03
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02008
Net income-$23.0M-$23.0M2008
Operating income-$31.9M-$31.9M2008
Total assets$4.4M$4.4M2008
Liabilities$6.4M$6.4M2008
Equity-$2.0M-$2.0M2008
Revenue trend
FY2001 – FY2008 · USD
FY01
FY02
FY03
FY04
FY05
FY06
FY07
FY08
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Xcorporeal, Inc.’s revenue?
Xcorporeal, Inc. booked $0 in FY2008 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Legacy Technology Holdings, Inc.——Pure Global Cannabis Inc.——Aamaxan Transport Group, Inc.——Speakeasy Cannabis Club Ltd.——Biomagnetics Diagnostics Corp.——PhaseRx, Inc.——Key facts
CEOVictor Gura
SectorHealthcare
IndustryMedical - Devices
HeadquartersLake Forest, null
ExchangeOTC: XCRP
Employees24
IPO date2000-01-03
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.